The Veterinary Record Link to Vetlife website
HOME CURRENT ISSUE TABLE OF CONTENTS ARCHIVE SEARCH SUBSCRIPTIONS JOBS FEEDBACK HELP
 QUICK SEARCH:   [advanced]


     


Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rijnberk, A
Right arrow Articles by Mol, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rijnberk, A
Right arrow Articles by Mol, J.
The Veterinary Record, Vol 122, Issue 8, 178-180
Copyright © 1988 by British Veterinary Association


Papers & Articles

Assessment of two tests for the diagnosis of canine hyperadrenocorticism

A Rijnberk, A van Wees, and JA Mol

Small Animal Clinic, Faculty of Veterinary Medicine, State University of Utrecht, The Netherlands.

The low-dose dexamethasone suppression test and the urinary corticoid/creatinine ratio were assessed in 166 and 150 dogs, respectively, for their value in the diagnosis of hyperadrenocorticism. The diagnostic accuracy of the low-dose dexamethasone suppression test was 0.83, with a 95 per cent confidence interval from 0.76 to 0.88. The urinary corticoid/creatinine ratio had a diagnostic accuracy of 0.91 with a 95 per cent confidence interval from 0.85 to 0.95. The high predictive value of a negative corticoid/creatinine ratio (0.98; confidence interval 0.80 to 1.00) and the low cost of this test makes it preferable for screening purposes to the low-dose dexamethasone suppression test for which the predictive value of a negative test was calculated as 0.5g (confidence interval 0.43 to 0.73).


This article has been cited by other articles:


Home page
EndocrinologyHome page
C. de Bruin, J. M. Hanson, B. P. Meij, H. S. Kooistra, A. M. Waaijers, P. Uitterlinden, S. W. J. Lamberts, and L. J. Hofland
Expression and Functional Analysis of Dopamine Receptor Subtype 2 and Somatostatin Receptor Subtypes in Canine Cushing's Disease
Endocrinology, September 1, 2008; 149(9): 4357 - 4366.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
J M Hanson, H S Kooistra, J A Mol, E Teske, and B P Meij
Plasma profiles of adrenocorticotropic hormone, cortisol, {alpha}-melanocyte-stimulating hormone, and growth hormone in dogs with pituitary-dependent hyperadrenocorticism before and after hypophysectomy.
J. Endocrinol., September 1, 2006; 190(3): 601 - 609.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. Castillo, D. Giacomini, M. Paez-Pereda, J. Stalla, M. Labeur, M. Theodoropoulou, F. Holsboer, A. B. Grossman, G. K. Stalla, and E. Arzt
Retinoic Acid as a Novel Medical Therapy for Cushing's Disease in Dogs
Endocrinology, September 1, 2006; 147(9): 4438 - 4444.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE TABLE OF CONTENTS ARCHIVE SEARCH SUBSCRIPTIONS JOBS FEEDBACK HELP
Copyright © 1988 British Veterinary Association